ATE475098T1 - Verfahren zur messung von plasmaspiegeln von pentraxin ptx3 - Google Patents
Verfahren zur messung von plasmaspiegeln von pentraxin ptx3Info
- Publication number
- ATE475098T1 ATE475098T1 AT06842803T AT06842803T ATE475098T1 AT E475098 T1 ATE475098 T1 AT E475098T1 AT 06842803 T AT06842803 T AT 06842803T AT 06842803 T AT06842803 T AT 06842803T AT E475098 T1 ATE475098 T1 AT E475098T1
- Authority
- AT
- Austria
- Prior art keywords
- ptx3
- plasma levels
- measuring plasma
- pentraxin ptx3
- plasma
- Prior art date
Links
- 101001082142 Homo sapiens Pentraxin-related protein PTX3 Proteins 0.000 title abstract 4
- BFHAYPLBUQVNNJ-UHFFFAOYSA-N Pectenotoxin 3 Natural products OC1C(C)CCOC1(O)C1OC2C=CC(C)=CC(C)CC(C)(O3)CCC3C(O3)(O4)CCC3(C=O)CC4C(O3)C(=O)CC3(C)C(O)C(O3)CCC3(O3)CCCC3C(C)C(=O)OC2C1 BFHAYPLBUQVNNJ-UHFFFAOYSA-N 0.000 title abstract 4
- 102100027351 Pentraxin-related protein PTX3 Human genes 0.000 title abstract 4
- 241001465754 Metazoa Species 0.000 abstract 2
- 230000004523 agglutinating effect Effects 0.000 abstract 1
- 239000013060 biological fluid Substances 0.000 abstract 1
- 210000003743 erythrocyte Anatomy 0.000 abstract 1
- 230000036470 plasma concentration Effects 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5002—Partitioning blood components
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/71—Assays involving receptors, cell surface antigens or cell surface determinants for growth factors; for growth regulators
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Spectrometry And Color Measurement (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
- Lasers (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/IT2006/000872 WO2008078344A1 (en) | 2006-12-22 | 2006-12-22 | A method for measuring plasma levels of long pentraxin ptx3 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE475098T1 true ATE475098T1 (de) | 2010-08-15 |
Family
ID=38050157
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06842803T ATE475098T1 (de) | 2006-12-22 | 2006-12-22 | Verfahren zur messung von plasmaspiegeln von pentraxin ptx3 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20090317843A1 (de) |
| EP (1) | EP2092342B1 (de) |
| JP (1) | JP2010513917A (de) |
| CN (1) | CN101606067A (de) |
| AT (1) | ATE475098T1 (de) |
| AU (1) | AU2006352299A1 (de) |
| CA (1) | CA2671139A1 (de) |
| DE (1) | DE602006015727D1 (de) |
| WO (1) | WO2008078344A1 (de) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5334742B2 (ja) * | 2009-08-11 | 2013-11-06 | 関東化学株式会社 | 水溶性アンモニウムポリマーを含有する検体前処理試薬、および検体前処理方法 |
| US20120034706A1 (en) * | 2010-08-06 | 2012-02-09 | Hakujyujikai Medical Inc. | Method for assessing inflammatory condition |
| GB201309358D0 (en) | 2013-05-24 | 2013-07-10 | King S College London | Aiding assessment of prognosis in inflammatory disease |
| MY160723A (en) * | 2013-12-30 | 2017-03-15 | Univ Putra Malaysia | An anticoagulant |
| MY174368A (en) * | 2014-12-09 | 2020-04-13 | Kao Corp | Sanitary product and agent for treating sanitary product |
| TWI741216B (zh) * | 2017-09-19 | 2021-10-01 | 臻崴生物科技有限公司 | 專一性抑制或減緩ｐｔｘ３與ｐｔｘ３受體結合之單株抗體或其抗原結合片段及其用途 |
| TWI754171B (zh) | 2018-09-14 | 2022-02-01 | 臻崴生物科技有限公司 | 含單株抗體或其抗原結合片段之醫藥組成物及其用途 |
| CN110514844A (zh) * | 2019-08-14 | 2019-11-29 | 湖南山河生物医学技术孵化中心(有限合伙) | 一种人五聚素3磁微粒化学发光免疫定量检测试剂盒及其制备方法 |
| CN111024956A (zh) * | 2019-12-31 | 2020-04-17 | 江苏美克医学技术有限公司 | 一种检测ptx3的时间分辨荧光免疫层析试剂盒 |
| AU2022343290A1 (en) * | 2021-09-10 | 2024-03-21 | Ortho-Clinical Diagnostics, Inc. | Agglutinating agents, devices and methods for whole blood assays |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1325043A (en) * | 1969-08-04 | 1973-08-01 | Greenspan D J | Method of separating blood components |
| US5652148A (en) * | 1993-04-20 | 1997-07-29 | Actimed Laboratories, Inc. | Method and apparatus for red blood cell separation |
| FR2774473B1 (fr) * | 1998-02-05 | 2000-05-12 | Pasteur Sanofi Diagnostics | Procede de dosage des troponines dans des milieux biologiques permettant d'eviter les interferences dues a l'heparine |
| WO2002027316A2 (en) * | 2000-09-25 | 2002-04-04 | Abbott Laboratories | Methods and kits for decreasing interferences of assays samples containing plasma or serum in specific binding assays by using a large polycation |
| US20040137544A1 (en) * | 2002-10-31 | 2004-07-15 | Roberto Latini | PTX3 as an early prognostic indicator of cardiovascular and cerebrovascular pathologies |
| EP1720014A4 (de) * | 2004-02-25 | 2008-01-16 | Perseus Proteomics Inc | Verfahren zur beurteilung des ausmasses einer vaskulopathie |
| ITMI20040858A1 (it) * | 2004-04-29 | 2004-07-29 | Farma Dev S R L | Anticorpi monoclonali ibridomi metodo migliorato per determinare la proteina ptx3 e kit per detta determinazione |
| AU2006331093B2 (en) * | 2005-12-29 | 2011-11-24 | Humanitas Mirasole S.P.A. | Diagnostic test for inflammatory endothelial dysfunctions in pregnancies |
-
2006
- 2006-12-22 WO PCT/IT2006/000872 patent/WO2008078344A1/en not_active Ceased
- 2006-12-22 EP EP06842803A patent/EP2092342B1/de not_active Not-in-force
- 2006-12-22 DE DE602006015727T patent/DE602006015727D1/de active Active
- 2006-12-22 CN CNA2006800566662A patent/CN101606067A/zh active Pending
- 2006-12-22 US US12/520,059 patent/US20090317843A1/en not_active Abandoned
- 2006-12-22 AU AU2006352299A patent/AU2006352299A1/en not_active Abandoned
- 2006-12-22 JP JP2009542399A patent/JP2010513917A/ja active Pending
- 2006-12-22 CA CA002671139A patent/CA2671139A1/en not_active Abandoned
- 2006-12-22 AT AT06842803T patent/ATE475098T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP2092342B1 (de) | 2010-07-21 |
| US20090317843A1 (en) | 2009-12-24 |
| CN101606067A (zh) | 2009-12-16 |
| WO2008078344A1 (en) | 2008-07-03 |
| DE602006015727D1 (de) | 2010-09-02 |
| JP2010513917A (ja) | 2010-04-30 |
| EP2092342A1 (de) | 2009-08-26 |
| CA2671139A1 (en) | 2008-07-03 |
| AU2006352299A1 (en) | 2008-07-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE112008000683A5 (de) | Messeinrichtung und Verfahren zur optischen Konzentrationsbestimmung von Blutzucker und/oder Laktat in biologischen Systemen | |
| EP2520935A3 (de) | Organspezifische Proteine und Verfahren zu deren Verwendung | |
| WO2014170497A3 (en) | Method for identifying the quantitative cellular composition in a biological sample | |
| BRPI0916624A2 (pt) | anticorpos monoclonais seletivos anti-hepcidina-25, seus usos, bem como método e kit para quantificar a quantidade de proteína hepcidina-25 em uma amostra de tecido ou fluido biológico | |
| NZ601590A (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
| BR112016004320A2 (pt) | biossensor, sistema, kit, métodos de determinação ou de identificação e de quantificação de uma concentração de amônia ou íon amônio, de diagnóstico de uma doença metabólica em um sujeito, de determinação da resposta do paciente a uma terapia, de fabricação de um biossensor, de um sistema ou de qualquer tira de teste e de detecção da presença, ausência, ou quantidade de aminoácidos em uma amostra, e, tira de teste | |
| ATE474228T1 (de) | Reagenz für hämoglobinabbau | |
| BRPI0717633A2 (pt) | Anticorpo, composição farmacêutica, e, métodos para detectar uma célula expressando cxcr7 em uma amostra biológica, para tratar, prevenir ou melhorar uma doença e para identificar um modulador de cxcr7 | |
| EP2662453A3 (de) | Nachweis und Behandlung von Schizophrenie | |
| CY1112423T1 (el) | Αναλυτικη συσκευη μικροεπεξεργαστη μιας χρησης | |
| EA201391627A1 (ru) | Анализ на наличие лизилоксидазоподобных белков 2 и способы его применения | |
| MX2020006728A (es) | Metodos para medir analito y/o proteina en muestras biologicas. | |
| DE602006015727D1 (de) | Verfahren zur messung von plasmaspiegeln von pentraxin ptx3 | |
| EP3714276C0 (de) | Testsensoren, systeme und analyseverfahren zur messung von glykiertem hämoglobin in unverdünnten blutproben | |
| DE60315715D1 (de) | Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs | |
| DE602007010246D1 (de) | Verfahren zur blutgerinnungsbestimmung | |
| EP3736571A4 (de) | Verfahren, reagenz und chip zur messung der analytkonzentration in einer biologischen probe | |
| DE602006018721D1 (de) | Cyanidfreie lösungsmittelzusammensetzung und verwendungsverfahren dafür zur messung von hämoglobin und weissen blutkörperchen | |
| DE602007006671D1 (de) | Verwendung von nnmt als marker für lungenkrebs | |
| EP2259058A4 (de) | Verfahren zur messung eines hämatokritwertes oder einer blutkomponentenkonzentration sowie entsprechendes messsystem | |
| MX2009001070A (es) | Uso de proteina con actividad inhibidora de melanoma (mia) como un indicador temprano para la respuesta terapeutica en melanoma. | |
| ATE550668T1 (de) | Verfahren zur identifizierung von patienten mit erhöhtem risiko für ein unerwünschtes herz- kreislauf-ereignis | |
| FI20040255A7 (fi) | Menetelmä pre-eklampsian riskin havaitsemiseksi | |
| ATE503846T1 (de) | Verfahren zur diagnose eines ovarialkarzinoms | |
| NZ599813A (en) | Reagents and methods for detecting pnh type ii white blood cells and their identification as risk factors for thrombotic disorders |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |